NAB815 would represent a useful tool in preventing HUS and is effective at sub-bactericidal concentrations, thus overcoming the concern that antibiotics are harmful to patients infected with Stx2-producing E. coli. The gene discussed is STX2; the disease is hemolytic-uremic syndrome.